{"nct_id":"NCT00109109","title":"A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)","status":"TERMINATED","status_verified_date":"2019-11","start_date":"2003-12-01","start_date_type":"ACTUAL","primary_completion_date":"2006-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2006-02-14","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}